EUVIMEDEUVIMED entdecken
Fallbericht

Fulminant Type 1 Diabetes Caused by DIHS Could Be Affected by the Reactivation of HHV-6

Hideichi Makino iD, Mikiko Tohyama iD, Ryoichi Kawamura, Yasunori Takata, Haruhiko Osawa iD, Hiroshi Onuma iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae058 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Hideichi Makino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan. Hauptthemen laut MEDLINE: Herpesvirus 6, Human, Diabetes Mellitus, Type 1, Roseolovirus Infections, Virus Activation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

In the previous issue of this journal, we reported that the incidence of fulminant type 1 diabetes (FT1D) due to the drug-induced hypersensitivity syndrome (DIHS) in Japan is higher than that in the general population and is associated with HLAB62. On the other hand, the reactivation of human herpesvirus 6 (HHV-6), which has been reported to be associated with DIHS, was observed at a higher frequency, but its association with the development of FT1D was unclear.

Objective

We aimed to clarify the relationship between the onset of FT1D and the reactivation of HHV-6.

Methods

We conducted a literature search for cases of DIHS-induced FT1D in addition to previously reported cases and investigated the changes in the HHV-6 antibody titer before and after the onset of FT1D.

Results

The HHV-6 antibody titer was increased just before or after the onset of FT1D in all 8 cases. In 1 case, HHV-6 DNA was also identified shortly before the onset of FT1D.

Conclusion

These results indicate for the first time that the reactivation of HHV-6 is associated with the onset of FT1D caused by DIHS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 6, HumanDiabetes Mellitus, Type 1Roseolovirus InfectionsVirus ActivationHumansDrug Hypersensitivity SyndromeFemaleMaleAdultJapan

Stichwörter der Autor:innen

cytomegalovirus (CMV)drug-induced hypersensitivity syndrome (DIHS)fulminant type 1 diabetes (FT1D)human herpes virus 6 (HHV-6)immune reconstitution inflammatory syndrome (IRIS)

Autor:innen und Institutionen

  • Department of Diabetes and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
  • Department of Dermatology, National Hospital Organization Shikoku Cancer Center, Ehime 791-0280, Japan.

ORCID-Profile: Hideichi Makino, Mikiko Tohyama, Haruhiko Osawa, Hiroshi Onuma

Zitieren

APA

Makino, H., Tohyama, M., Kawamura, R., Takata, Y., Osawa, H., & Onuma, H. (2024). Fulminant Type 1 Diabetes Caused by DIHS Could Be Affected by the Reactivation of HHV-6. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae058

Vancouver

Makino H, Tohyama M, Kawamura R, Takata Y, Osawa H, Onuma H. Fulminant Type 1 Diabetes Caused by DIHS Could Be Affected by the Reactivation of HHV-6. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae058

BibTeX
@article{Makino2024,
  author = {Makino, Hideichi and Tohyama, Mikiko and Kawamura, Ryoichi and Takata, Yasunori and Osawa, Haruhiko and Onuma, Hiroshi},
  title = {Fulminant Type 1 Diabetes Caused by DIHS Could Be Affected by the Reactivation of HHV-6},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae058}
}
Kostenlos starten →